Twist Bioscience Corp Quarterly Income Tax Expense (Benefit) in USD from Q4 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Twist Bioscience Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q4 2017 to Q3 2024.
  • Twist Bioscience Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was -$96K, a 56.8% increase year-over-year.
  • Twist Bioscience Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $560K, a 51.4% decline year-over-year.
  • Twist Bioscience Corp annual Income Tax Expense (Benefit) for 2024 was $560K, a 51.4% decline from 2023.
  • Twist Bioscience Corp annual Income Tax Expense (Benefit) for 2023 was $1.15M.
  • Twist Bioscience Corp annual Income Tax Expense (Benefit) for 2022 was -$10.4M, a 439% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $560K -$96K +$126K +56.8% Jul 1, 2024 Sep 30, 2024 10-K 2024-11-18
Q2 2024 $434K $191K -$431K -69.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-02
Q1 2024 $865K $345K -$331K -49% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $1.2M $120K +$44K +57.9% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-02
Q3 2023 $1.15M -$222K -$514K -176% Jul 1, 2023 Sep 30, 2023 10-K 2024-11-18
Q2 2023 $1.67M $622K +$771K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-02
Q1 2023 $895K $676K +$825K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $70K $76K +$10.5M Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-02
Q3 2022 -$10.4M $292K -$48K -14.1% Jul 1, 2022 Sep 30, 2022 10-K 2024-11-18
Q2 2022 -$10.4M -$149K +$2.23M +93.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 -$12.6M -$149K -$210K -344% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$12.4M -$10.4M -$10.5M -22720% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-07
Q3 2021 -$1.93M $340K +$77K +29.3% Jul 1, 2021 Sep 30, 2021 10-K 2023-11-21
Q2 2021 -$2.01M -$2.38M -$2.4M -11419% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $391K $61K $0 0% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $391K $46K +$9K +24.3% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 $382K $263K +$152K +137% Jul 1, 2020 Sep 30, 2020 10-K/A 2023-06-05
Q2 2020 $230K $21K -$33K -61.1% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $263K $61K -$23K -27.4% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $286K $37K -$6K -14% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-09
Q3 2019 $292K $111K +$35K +46.1% Jul 1, 2019 Sep 30, 2019 10-K 2021-11-23
Q2 2019 $257K $54K -$17K -23.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $274K $84K +$41K +95.3% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 $233K $43K -$9K -17.3% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 $242K $76K Jul 1, 2018 Sep 30, 2018 10-K 2020-11-27
Q2 2018 $71K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 $43K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q4 2017 $52K Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.